Aborted sudden cardiac death in children and adolescents-from acute management to diagnosis.
- 1Department of Paediatrics & Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
- 2Division of Cardiology, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
Aborted sudden cardiac death (SCD) in children and adolescents is terrifying for patients and families. Inherited arrhythmia syndromes, cardiomyopathies, and coronary anomalies are the most common associations. This review provides a comprehensive framework for diagnostic evaluation in survivors of resuscitated sudden cardiac arrest. After hemodynamic stabilization and neuroprotection, evaluation often requires data retrieval, structured cardiac phenotyping, and obtaining samples to assess for molecular, metabolic or toxicology analysis. A tiered approach is essential. A surface electrocardiogram (ECG) and echocardiography remain first line investigations. Primary electrical diseases may be evident on a standard and modified ECG, including Wolff-Parkinson-White (WPW) syndrome, conduction abnormalities, myocardial ischemia, and some cardiac channelopathies. Early echocardiography assesses structural heart disease, cardiomyopathies and myocarditis. Special attention should be paid to anomalous origin of the coronary arteries and recent work has emphasized the importance of mitral annular disjunction. Cardiac magnetic resonance imaging, exercise stress testing, and drug provocation testing can be useful supplements to reveal concealed substrates. Genetic testing is vital for precision medicine and cascade family screening, often requiring a multidisciplinary team to assess variants of uncertain significance (VUS) and complex genomic findings. Ultimately, the critical step is genotype-phenotype correlation, where the team determines whether the genetic and clinical data reinforce one another to provide a diagnosis, refine treatment, and prevent future tragedies within affected families.
Related
- NKX2-5 mutation in a family with ventricular tachycardia and aborted sudden cardiac death.
- QuickStats: Percentage* of Children and Adolescents Aged 5–17 Years Who Had Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Sex and Year — United States, 2019–2025
- The Emerging Phenotype of HFpEF in Cardiac Allografts: A Review of Pathophysiology, Diagnosis, and Management
- Immature teratoma of the ovary in children and adolescents: A multi-institutional study of characteristics and management
- Surgery during regorafenib therapy in children, adolescents, and young adults with bone sarcomas: perioperative management and feasibility
BibTeX
@article{kwok2026aborted,
title = {{Aborted sudden cardiac death in children and adolescents-from acute management to diagnosis.}},
author = {Sit-Yee Kwok and Gregory Webster},
journal = {Translational pediatrics},
year = {2026},
month = oct,
doi = {10.21037/tp-2026-0475},
url = {https://europepmc.org/article/MED/42996390},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Aborted sudden cardiac death in children and adolescents-from acute management to diagnosis.
AU - Sit-Yee Kwok
AU - Gregory Webster
PY - 2026
DA - 2026/10/23
JO - Translational pediatrics
DO - 10.21037/tp-2026-0475
UR - https://europepmc.org/article/MED/42996390
AB - Aborted sudden cardiac death (SCD) in children and adolescents is terrifying for patients and families. Inherited arrhythmia syndromes, cardiomyopathies, and coronary anomalies are the most common associations. This review provides a comprehensive framework for diagnostic evaluation in survivors of resuscitated sudden cardiac arrest. After hemodynamic stabilization and neuroprotection, evaluation often requires data retrieval, structured cardiac phenotyping, and obtaining samples to assess for molecular, metabolic or toxicology analysis. A tiered approach is essential. A surface electrocardiogram (ECG) and echocardiography remain first line investigations. Primary electrical diseases may be evident on a standard and modified ECG, including Wolff-Parkinson-White (WPW) syndrome, conduction abnormalities, myocardial ischemia, and some cardiac channelopathies. Early echocardiography assesses structural heart disease, cardiomyopathies and myocarditis. Special attention should be paid to anomalous origin of the coronary arteries and recent work has emphasized the importance of mitral annular disjunction. Cardiac magnetic resonance imaging, exercise stress testing, and drug provocation testing can be useful supplements to reveal concealed substrates. Genetic testing is vital for precision medicine and cascade family screening, often requiring a multidisciplinary team to assess variants of uncertain significance (VUS) and complex genomic findings. Ultimately, the critical step is genotype-phenotype correlation, where the team determines whether the genetic and clinical data reinforce one another to provide a diagnosis, refine treatment, and prevent future tragedies within affected families.
SN - 2224-4336
SN - 2224-4344
ER -